Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Zaag
    Senior Member
    • Nov 2009
    • 112

    #1

    %varfreq homozygote off to 30%

    We do resequencing on the 454 and the SOLiD. We do whole exomes (Nimblegen) and we do a small custom region (Nimblegen, 1kb).

    When we plot a histogram of our variant frequencies we get what we expect for the small region on the 454 but when we do the same for the whole exome or small region capture on the SOLiD there seem to be not enough reads with variant and when we try'd to validate with Sanger we got homozygotes in Sanger that were off to 30% variantfrequency on the SOLiD capture

    Does anyone have a thought on this?
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    I'm not a wet lab kind of guy, I deal more with big data ... but ... check to see if there's a known segment duplication/deletion/variation in your region of interest. The UCSC browser has these "segmental variation" tracks. You might need to adjust the region that you're cutting out based on this information. A good example of a "cryptic duplication" is at the PRIM2 gene area mapped against the reference (higher whole genome coverage there and tri-nucleotide SNPS).
    Last edited by Richard Finney; 05-26-2011, 08:04 AM. Reason: grammerr

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...